These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 34352109)

  • 1. Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis.
    Witkowski M; Witkowski M; Friebel J; Buffa JA; Li XS; Wang Z; Sangwan N; Li L; DiDonato JA; Tizian C; Haghikia A; Kirchhofer D; Mach F; Räber L; Matter CM; Tang WHW; Landmesser U; Lüscher TF; Rauch U; Hazen SL
    Cardiovasc Res; 2022 Jul; 118(10):2367-2384. PubMed ID: 34352109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
    Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.
    Zhu W; Buffa JA; Wang Z; Warrier M; Schugar R; Shih DM; Gupta N; Gregory JC; Org E; Fu X; Li L; DiDonato JA; Lusis AJ; Brown JM; Hazen SL
    J Thromb Haemost; 2018 Sep; 16(9):1857-1872. PubMed ID: 29981269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethylamine N-oxide promotes tissue factor expression and activity in vascular endothelial cells: A new link between trimethylamine N-oxide and atherosclerotic thrombosis.
    Cheng X; Qiu X; Liu Y; Yuan C; Yang X
    Thromb Res; 2019 May; 177():110-116. PubMed ID: 30875490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.
    Gupta N; Buffa JA; Roberts AB; Sangwan N; Skye SM; Li L; Ho KJ; Varga J; DiDonato JA; Tang WHW; Hazen SL
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1239-1255. PubMed ID: 32212854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential.
    Skye SM; Zhu W; Romano KA; Guo CJ; Wang Z; Jia X; Kirsop J; Haag B; Lang JM; DiDonato JA; Tang WHW; Lusis AJ; Rey FE; Fischbach MA; Hazen SL
    Circ Res; 2018 Oct; 123(10):1164-1176. PubMed ID: 30359185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.
    Wang Z; Tang WH; Buffa JA; Fu X; Britt EB; Koeth RA; Levison BS; Fan Y; Wu Y; Hazen SL
    Eur Heart J; 2014 Apr; 35(14):904-10. PubMed ID: 24497336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodelling of gut microbiota by Berberine attenuates trimethylamine N-oxide-induced platelet hyperreaction and thrombus formation.
    Xie Z; Liu X; Huang X; Liu Q; Yang M; Huang D; Zhao P; Tian J; Wang X; Hou J
    Eur J Pharmacol; 2021 Nov; 911():174526. PubMed ID: 34599914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes.
    Haghikia A; Li XS; Liman TG; Bledau N; Schmidt D; Zimmermann F; Kränkel N; Widera C; Sonnenschein K; Haghikia A; Weissenborn K; Fraccarollo D; Heimesaat MM; Bauersachs J; Wang Z; Zhu W; Bavendiek U; Hazen SL; Endres M; Landmesser U
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2225-2235. PubMed ID: 29976769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
    Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C
    Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bacterial metabolite, trimethylamine N-oxide, disrupts the hemostasis balance in human primary endothelial cells but no coagulopathy in mice.
    Subramaniam S; Boukhlouf S; Fletcher C
    Blood Coagul Fibrinolysis; 2019 Oct; 30(7):324-330. PubMed ID: 31490208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota-Derived Trimethylamine N-Oxide Contributes to Abdominal Aortic Aneurysm Through Inflammatory and Apoptotic Mechanisms.
    Benson TW; Conrad KA; Li XS; Wang Z; Helsley RN; Schugar RC; Coughlin TM; Wadding-Lee C; Fleifil S; Russell HM; Stone T; Brooks M; Buffa JA; Mani K; Björck M; Wanhainen A; Sangwan N; Biddinger S; Bhandari R; Ademoya A; Pascual C; Tang WHW; Tranter M; Cameron SJ; Brown JM; Hazen SL; Owens AP
    Circulation; 2023 Apr; 147(14):1079-1096. PubMed ID: 37011073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
    Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
    Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk.
    Li XS; Wang Z; Cajka T; Buffa JA; Nemet I; Hurd AG; Gu X; Skye SM; Roberts AB; Wu Y; Li L; Shahen CJ; Wagner MA; Hartiala JA; Kerby RL; Romano KA; Han Y; Obeid S; Lüscher TF; Allayee H; Rey FE; DiDonato JA; Fiehn O; Tang WHW; Hazen SL
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.
    Zhu W; Gregory JC; Org E; Buffa JA; Gupta N; Wang Z; Li L; Fu X; Wu Y; Mehrabian M; Sartor RB; McIntyre TM; Silverstein RL; Tang WHW; DiDonato JA; Brown JM; Lusis AJ; Hazen SL
    Cell; 2016 Mar; 165(1):111-124. PubMed ID: 26972052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonlethal Inhibition of Gut Microbial Trimethylamine N-oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure.
    Organ CL; Li Z; Sharp TE; Polhemus DJ; Gupta N; Goodchild TT; Tang WHW; Hazen SL; Lefer DJ
    J Am Heart Assoc; 2020 May; 9(10):e016223. PubMed ID: 32390485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbes impact stroke severity via the trimethylamine N-oxide pathway.
    Zhu W; Romano KA; Li L; Buffa JA; Sangwan N; Prakash P; Tittle AN; Li XS; Fu X; Androjna C; DiDonato AJ; Brinson K; Trapp BD; Fischbach MA; Rey FE; Hajjar AM; DiDonato JA; Hazen SL
    Cell Host Microbe; 2021 Jul; 29(7):1199-1208.e5. PubMed ID: 34139173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
    Romano KA; Vivas EI; Amador-Noguez D; Rey FE
    mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis.
    Yang W; Zhang S; Zhu J; Jiang H; Jia D; Ou T; Qi Z; Zou Y; Qian J; Sun A; Ge J
    J Mol Cell Cardiol; 2019 Sep; 134():119-130. PubMed ID: 31299216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.